Economy & Economic Development  May 15, 2018

Corden Pharma expands capacity, staff in Boulder

BOULDER — Corden Pharma is expanding its capabilities to manufacture active pharmaceutical ingredients at the east Boulder plant it acquired in 2011 from Roche Colorado Corp.

The expansion will allow the company to increase its production of oligonucleotides, which are chemically synthesized short nucleic acid polymers that are designed to fuse with DNA or ribonucleic acid sequences. They’re used to treat some cancers as well as infectious and genetic diseases.

The expansion at the plant at 2075 55th St., which was completed in the first quarter of this year, amounted to “renovation of existing space…

With BizWest since 2012 and in Colorado since 1979, Dallas worked at the Longmont Times-Call, Colorado Springs Gazette, Denver Post and Public News Service. A Missouri native and Mizzou School of Journalism grad, Dallas started as a sports writer and outdoor columnist at the St. Charles (Mo.) Banner-News, then went to the St. Louis Post-Dispatch before fleeing the heat and humidity for the Rockies. He especially loves covering our mountain communities.

Related Posts

Sign up for BizWest Daily Alerts
Closing in 8 seconds...